{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:54:46Z","timestamp":1789844086206,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009923","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000}}],"reference-count":66,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009923.pub2","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T18:16:28Z","timestamp":1432750588000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Tapentadol for chronic musculoskeletal pain in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Jo\u00e3o","family":"Santos","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine; Faculty of Medicine, University of Lisbon; Lisbon Portugal"},{"name":"Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Faculdade de Medicina de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Alarc\u00e3o","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine; Faculty of Medicine, University of Lisbon; Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Fareleira","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine; Faculty of Medicine, University of Lisbon; Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Vaz Carneiro","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine; Faculty of Medicine, University of Lisbon; Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine; Faculty of Medicine, University of Lisbon; Lisbon Portugal"},{"name":"Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Faculdade de Medicina de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD009923.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11533440-000000000-00000","article-title":"Efficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study","volume":"30","author":"Afilalo","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"s1","key":"10.1002\/14651858.CD009923.pub2-BIB0002|cit2","first-page":"159","article-title":"Efficacy and safety of tapentadol extended release (ER) for chronic pain due to osteoarthritis of the knee: results of a phase 3 study","volume":"9","author":"Afilalo","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S1063-4584(09)60350-2","article-title":"Efficacy and safety of tapentadol extended release versus oxycodone controlled release in opioid-naive and opioid-experienced patients with chronic pain associated with osteoarthritis of the knee","volume":"17","author":"Etropolski","year":"2009","journal-title":"Osteoarthritis and Cartilage"},{"issue":"7","key":"10.1002\/14651858.CD009923.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"A433","DOI":"10.1016\/S1098-3015(10)75144-5","article-title":"EuroQol-5 dimension health status questionnaire results from a randomized, double-blind, placebo- and active-controlled Phase 3 study of tapentadol extended release (ER) for the management of chronic osteoarthritis knee pain","volume":"12","author":"Kavanagh","year":"2009","journal-title":"Value Health"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0005|cit5","first-page":"i79","article-title":"Similar analgesic effect and improved tolerability of tapentadol extended release (ER) versus oxycodone controlled release (CR) for treatment of chronic osteoarthritis (OA) knee pain: results from a randomized, double-blind, phase 3 trial","volume":"49","author":"Kelly","year":"2010","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0006|cit6","first-page":"850","article-title":"Effects of tapentadol extended release on the Western Ontario and McMaster universities osteoarthritis index (WOMAC) and pain intensity in patients with chronic osteoarthritis pain: results of a randomized, phase 3, active- and placebo-controlled study","volume":"60","author":"Kelly","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"S1","key":"10.1002\/14651858.CD009923.pub2-BIB0007|cit7","first-page":"161-2","article-title":"Efficacy and gastrointestinal tolerability of tapentadol extended release in a randomized, double-blind, placebo- and active-controlled study in patients with moderate-to-severe chronic osteoarthritis knee pain","volume":"9","author":"Kelly","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S1063-4584(09)60356-3","article-title":"Incidence and severity of gastrointestinal treatment-emergent adverse events in patients treated with tapentadol extended release (ER) or oxycodone controlled release (CR) for relief of chronic osteoarthritis knee pain","volume":"17","author":"Kuperwasser","year":"2009","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S1063-4584(09)60358-7","article-title":"Tapentadol extended release for the relief of chronic osteoarthritis knee pain: results from the EuroQol-5 dimension (EQ-5D) and Western Ontario and McMaster Universities osteoarthritis index (WOMAC) questionnaires","volume":"17","author":"Rauschkolb","year":"2009","journal-title":"Osteoarthritis and Cartilage"},{"issue":"1","key":"10.1002\/14651858.CD009923.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.36076\/ppj.2013\/16\/27","article-title":"Efficacy of tapentadol ER for managing moderate to severe chronic pain","volume":"16","author":"Afilalo","year":"2013","journal-title":"Pain Physician"},{"issue":"5","key":"10.1002\/14651858.CD009923.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5055\/jom.2013.0177","article-title":"A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain","volume":"9","author":"Etropolski","year":"2013","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1002\/14651858.CD009923.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5055\/jom.2013.0147","article-title":"Composite measure to assess efficacy\/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies","volume":"9","author":"Merchant","year":"2013","journal-title":"Journal of Opioid Management"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0013|cit13","first-page":"1494","article-title":"Dose stability of tapentadol ER for the relief of chronic low back pain: results of a randomized, active- and placebo-controlled study","volume":"60","author":"Buynak","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jpain.2009.01.202","article-title":"Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain","volume":"1","author":"Buynak","year":"2009","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jpain.2009.01.321","article-title":"Efficacy and safety of tapentadol ER for chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"1","author":"Buynak","year":"2009","journal-title":"Journal of Pain"},{"issue":"11","key":"10.1002\/14651858.CD009923.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","article-title":"Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study","volume":"11","author":"Buynak","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"16","key":"10.1002\/14651858.CD009923.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1517\/14656566.2010.526358","article-title":"Erratum: efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study (Expert Opinion on Pharmacotherapy (2010) 11(11): 1787-804)","volume":"11","author":"Buynak","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jpain.2009.01.275","article-title":"A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity","volume":"1","author":"Etropolski","year":"2009","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S1090-3801(09)60710-2","article-title":"Analysis of efficacy and safety of tapentadol extended release (ER) for chronic low back pain based on prior opioid experience","volume":"13","author":"Etropolski","year":"2009","journal-title":"European Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD009923.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"A376","DOI":"10.1016\/S1098-3015(10)74851-8","article-title":"Tapentadol extended release (ER) for chronic low back pain: results of EuroQol-5 dimension (EQ-5D) and Short Form-36 (SF-36) health status questionnaires","volume":"12","author":"Kavanagh","year":"2009","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0021|cit21","first-page":"i78","article-title":"Results of a randomized, double-blind, placebo- and active-controlled trial of tapentadol extended release for chronic low back pain","volume":"49","author":"Shapiro","year":"2010","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0022|cit22","first-page":"S42","article-title":"Safety and tolerability of tapentadol extended release (ER) versus oxycodone controlled release (CR) in elderly patients with chronic low back or osteoarthritis pain","volume":"1","author":"Biondi","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0023|cit23","first-page":"S42","article-title":"Tapentadol extended release (ER) versus oxycodone controlled release (CR) for management of chronic low back or osteoarthritis pain: Analyses of study discontinuations due to constipation, nausea, or vomiting","volume":"1","author":"Biondi","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0024|cit24","first-page":"S42","article-title":"Tapentadol extended release (ER) versus oxycodone controlled release (CR) for management of chronic low back or osteoarthritis pain: Influence of prior opioid experience on study discontinuations due to constipation, nausea, or vomiting","volume":"1","author":"Biondi","year":"2010","journal-title":"Journal of Pain"},{"issue":"S1","key":"10.1002\/14651858.CD009923.pub2-BIB0025|cit25","first-page":"92","article-title":"Tolerability of tapentadol extended release versus oxycodone controlled release in elderly patients with chronic low back or osteoarthritis pain in a 1-year safety study","volume":"24","author":"Blondi","year":"2010","journal-title":"Der Schmerz"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/S1063-4584(09)60364-2","article-title":"Dose stability of tapentadol extended release and oxycodone controlled release in a one-year, randomized, open-label, phase 3 safety trial in patients with chronic low back or osteoarthritis pain","volume":"17","author":"Grond","year":"2009","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0027|cit27","first-page":"1495","article-title":"Long-term safety and gastrointestinal tolerability of tapentadol extended release or oxycodone controlled release in patients with chronic low back or osteoarthritis pain","volume":"60","author":"Grond","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0028|cit28","first-page":"i78","article-title":"Tolerability of tapentadol extended release (ER) based on discontinuations because of adverse events in patients with moderate to severe chronic pain: results of a 1-year randomized phase 3 safety study","volume":"49","author":"Weber","year":"2010","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S1090-3801(09)60716-3","article-title":"Tolerability of tapentadol extended release (ER) based on discontinuations because of adverse events in patients with moderate-to-severe chronic pain","volume":"13","author":"Weber","year":"2009","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD009923.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1533-2500.2010.00397.x","article-title":"Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain","volume":"10","author":"Wild","year":"2010","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S1063-4584(10)60361-5","article-title":"Assessment of opioid withdrawal in patients treated with tapentadol prolonged release during an open-label extension study","volume":"18","author":"Ashworth","year":"2010","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S1063-4584(10)60364-0","article-title":"Health status of patients who received tapentadol prolonged release during an open-label extension study","volume":"18","author":"Kuperwasser","year":"2010","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0033|cit33","first-page":"950","article-title":"Patient Global Impression of Change results from a 1-year open-label extension study of tapentadol extended release in patients with chronic osteoarthritis or low back pain","volume":"62","author":"McCann","year":"2010","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD009923.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12325-013-0015-6","article-title":"Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study","volume":"30","author":"G\u00e1lvez","year":"2013","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD009923.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","article-title":"Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain","volume":"27","author":"Lange","year":"2010","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD009923.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00002508-199309000-00004","article-title":"Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization","volume":"9","author":"Andersson","year":"1993","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0037|cit37","unstructured":"Paliative and Supportive Care Group PaPaS Author and Referee Guidance (AUREF), 2012 papas.cochrane.org\/papas-documents"},{"issue":"1","key":"10.1002\/14651858.CD009923.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200003000-00005","article-title":"A comparison of pain rating scales by sampling from clinical trial data","volume":"16","author":"Breivik","year":"2000","journal-title":"Clinical Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD009923.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD009923.pub2-BIB0040|cit40","first-page":"1521","article-title":"The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services","volume":"27","author":"Buskila","year":"2000","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD009923.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0042|cit42","volume-title":"Epidemiology of Pain","author":"Crombie","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD009923.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD009923.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0045|cit45","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [update March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0046|cit46","first-page":"S1","article-title":"Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms","volume":"3","author":"International Association for the Study of Pain","year":"1986","journal-title":"Pain. Supplement"},{"issue":"23","key":"10.1002\/14651858.CD009923.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.1995.03530230056031","article-title":"The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation","volume":"274","author":"Jadad","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0048|cit48","first-page":"233","volume-title":"Sex, Gender, and Pain. Progress in Pain Research and Management","volume":"17","author":"LeResche","year":"2000"},{"issue":"2","key":"10.1002\/14651858.CD009923.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.36076\/ppj.2011\/14\/91","article-title":"A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain","volume":"14","author":"Manchikanti","year":"2011","journal-title":"Pain Physician"},{"issue":"5","key":"10.1002\/14651858.CD009923.pub2-BIB0050|cit50","first-page":"1331","article-title":"Treatment of nonmalignant chronic pain","volume":"61","author":"Marcus","year":"2000","journal-title":"American Family Physician"},{"issue":"3","key":"10.1002\/14651858.CD009923.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/31.3.189","article-title":"Knee pain and disability in the community","volume":"31","author":"McAlindon","year":"1992","journal-title":"British Journal of Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD009923.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-2-2","article-title":"Pooling data for number needed to treat: no problems for apples","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Medical Research Methodology"},{"issue":"3","key":"10.1002\/14651858.CD009923.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain-establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD009923.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003115.pub3","article-title":"Oral or transdermal opioids for osteoarthritis of the knee or hip","author":"N\u00fcesch","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"17","key":"10.1002\/14651858.CD009923.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/00007632-199509000-00009","article-title":"Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey","volume":"20","author":"Papageogiou","year":"1995","journal-title":"Spine"},{"issue":"11","key":"10.1002\/14651858.CD009923.pub2-BIB0057|cit57","first-page":"2400","article-title":"Factors associated with continued employment among patients with rheumatoid arthritis: a survival model","volume":"28","author":"Reisine","year":"2001","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0058|cit58","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"7","key":"10.1002\/14651858.CD009923.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"A411","DOI":"10.1016\/j.jval.2011.08.978","article-title":"A systematic review of tapentadol in chronic moderate to severe pain","volume":"14","author":"Riemsma","year":"2011","journal-title":"Value in Health"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009923.pub2-BIB0060|cit60","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009923.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009923.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.36076\/ppj.2008\/11\/S181","article-title":"Effectiveness of opioids in the treatment of chronic non-cancer pain","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"11","key":"10.1002\/14651858.CD009923.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ard.57.11.649","article-title":"Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation","volume":"57","author":"Urwin","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD009923.pub2-BIB0064|cit64","unstructured":"World Health Organization WHO's pain relief ladder 2010 www.who.int\/cancer\/palliative\/painladder\/en"},{"issue":"1","key":"10.1002\/14651858.CD009923.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011460","article-title":"Oral tapentadol for cancer pain","author":"Wiffen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009923.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009923","article-title":"Tapentadol for chronic musculoskeletal pain in adults","author":"Santos","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009923.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T09:47:24Z","timestamp":1678528044000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009923.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009923.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}